Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice.
about
Clinical Implications of Antiviral Resistance in InfluenzaInfluenza treatment and prophylaxis with neuraminidase inhibitors: a reviewNew small-molecule drug design strategies for fighting resistant influenza AA Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune ResponseIn vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice.Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.How I treat influenza in patients with hematologic malignancies.Combinations of L-NG-monomethyl-arginine and oseltamivir against pandemic influenza A virus infections in mice.ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION.Combination chemotherapy for influenza.Antiviral strategies for pandemic and seasonal influenzaCombinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.Newer influenza antivirals, biotherapeutics and combinations.Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.Favipiravir (T-705), a novel viral RNA polymerase inhibitor.Animal Models for Influenza Virus Pathogenesis and Transmission.How to approach and treat viral infections in ICU patientsAntiviral effect of methylated flavonol isorhamnetin against influenza.Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents.Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c miceCombinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in MiceIdentification of 23-(s)-2-amino-3-phenylpropanoyl-silybin as an antiviral agent for influenza A virus infection in vitro and in vivoHighlights in antiviral drug research: antivirals at the horizon.Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.Antiviral strategies against influenza virus: towards new therapeutic approaches.Comparison of three dimensional synergistic analyses of percentage versus logarithmic data in antiviral studies.Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases.Antiviral activity of 3,4'-dihydroxyflavone on influenza a virus.Influenza RNA-Dependent RNA Polymerase (RdRp) Inhibitors: Potential New Therapy for Influenza Treatment.Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors.Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase.Novel oral anti-influenza drug candidate AV5080.The Role of Extracellular Histones in Influenza Virus Pathogenesis.Influenza antivirals and resistance: the next 10 years?The mechanism of resistance to favipiravir in influenzaInvestigating Different Mechanisms of Action in Combination Therapy for Influenza
P2860
Q26782746-9A6296AB-BED2-4D46-821C-085480C54D62Q26860032-7A151F69-8858-489A-8518-C8987FD82246Q28080554-DE67F9A8-3649-445B-BF73-EB3C4D999306Q28553101-38D3A2ED-FCFC-477B-A22D-1129AEBA244EQ30356466-CEFAD830-18C6-4FC6-ADBF-855866F76C6AQ30359363-306C7B6B-1C61-499C-A4F8-13B82DF39542Q30364319-AC067C8C-2B05-456A-A9B6-F93D01690EC4Q30383456-F89A2FE8-6910-4146-A50F-A60E3D32E6D3Q30401138-543F20C5-B25F-424A-84ED-19B05A415B8CQ30404586-84AAD52C-72FC-45B7-B537-962F12CC7531Q30408112-300851CA-2E63-4F6C-9CE1-0D231CF674A8Q30408116-FDB4AD01-67D4-409E-A268-ACCCB4B9B413Q30414428-4BCF3EA4-A6D1-49B1-89EA-12E7E2161262Q30456363-CE62F4D6-FA53-42CF-BB05-DDFCFC14BBAAQ34159076-85CE14DB-1C2C-444E-8058-8CB20C5EB442Q34374652-B06EFC72-8C89-42ED-B301-923E3108BE7EQ34714853-F451D57F-2E2F-4C9D-B9B7-E44ED285B1C6Q34894660-DBEF6492-2194-4523-B59F-EE7FD091EE8CQ35217208-9D88DB4C-652F-4D47-B163-6D511CC1F8FDQ36301052-E02BCC6A-E65E-43A1-AF44-71B35089B455Q36607954-23C7878F-5341-4273-A82F-4E0F238402D6Q36934209-74C38530-FBCD-405A-B3E7-7BFD3E213AC4Q37124162-AED73ABF-9236-4944-A21B-19B2C5EE5812Q38007145-47103A4D-58FA-473D-9640-A04CA5949E0FQ38084212-F864E069-D747-4023-AC5D-F960C2D38925Q38202012-57D8A936-1399-495E-AD30-2500C60C2EF6Q38694084-42B4AD7E-938E-4D4B-B50C-509870E9BBF6Q38833628-88FB83C1-4E31-443D-84E0-F317957626C0Q38990682-A684EB4E-262B-4430-86BF-05B81FF4519CQ39777631-5B4A0383-0C7C-4470-B7A1-0BC2539C07F4Q40044875-5ABA64E2-3399-46A5-A8A1-E13784B0A9CCQ40743239-AC9D4EC9-4084-4D30-AC77-42EF2366AC7AQ42110040-461D32E1-B45E-4C11-8974-9D68181ADD65Q42224737-AFFAB27A-8780-42C5-AFDE-6D71C8EB92CDQ45325237-A1293C7B-511F-4891-9361-941CCBF49D48Q57240687-BD72D3AB-DA55-46CE-B50C-17329A8D3D4DQ57799444-5C6B0357-BDD0-4101-991E-68E3108B1381Q58573517-5F9DDCD3-0FF8-4D6F-A431-84EE2EA77D93
P2860
Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effects of the combination of ...... za A virus infections in mice.
@ast
Effects of the combination of ...... za A virus infections in mice.
@en
Effects of the combination of favipiravir
@nl
type
label
Effects of the combination of ...... za A virus infections in mice.
@ast
Effects of the combination of ...... za A virus infections in mice.
@en
Effects of the combination of favipiravir
@nl
prefLabel
Effects of the combination of ...... za A virus infections in mice.
@ast
Effects of the combination of ...... za A virus infections in mice.
@en
Effects of the combination of favipiravir
@nl
P2093
P2860
P356
P1476
Effects of the combination of ...... za A virus infections in mice.
@en
P2093
Brett L Hurst
E Bart Tarbet
Kevin W Bailey
Min-Hui Wong
Yousuke Furuta
P2860
P304
P356
10.1128/AAC.00933-09
P407
P577
2009-11-09T00:00:00Z